Profil
Gaurav Chandra is currently the Chief Executive Officer at Biogenysis, Inc. and Adnexus, Inc. He is also the Chief Executive Officer & Director at Adnexus Biotechnologies, Inc. and the Chief Operating Officer at Bioclonetics Immunotherapeutics, Inc. Previously, he served as the Director at Enzolytics, Inc. in 2024.
Dr. Chandra holds a doctorate degree from Albert Einstein College of Medicine, Inc., an undergraduate degree from Kasturba Medical College, and an MBA from the University of Colorado Denver.
Aktive Positionen von Gaurav Chandra
| Unternehmen | Position | Beginn |
|---|---|---|
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops human neutralizing monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy | Geschäftsführer | - |
Adnexus, Inc. LLC
Adnexus, Inc. LLC BiotechnologyHealth Technology Provides drug discovery AI solutions | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Gaurav Chandra
| Unternehmen | Position | Ende |
|---|---|---|
| ENZOLYTICS, INC. | Geschäftsführer | 19.03.2024 |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of species specific monoclonal antibodies against diseases | Vorstandsvorsitzender | 23.02.2024 |
Ausbildung von Gaurav Chandra
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Enzolytics, Inc.
Enzolytics, Inc. BiotechnologyHealth Technology Develops and commercializes of drugs for infectious disease treatments | Health Technology |
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kasturba Medical College
Kasturba Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Denver
University of Colorado Denver Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops human neutralizing monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy | Health Technology |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of species specific monoclonal antibodies against diseases | Commercial Services |
Adnexus, Inc. LLC
Adnexus, Inc. LLC BiotechnologyHealth Technology Provides drug discovery AI solutions | Health Technology |
















